Boston Scientific Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2025
Total Assets: $43.67B
Liabilities Breakdown FY2025
Total Liabilities: $19.44B
Asset Breakdown
Total Assets: $43.67B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.97B | 4.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $2.94B | 6.7% |
| Property, Plant & Equipment | $4.04B | 9.2% |
| Goodwill | $18.28B | 41.9% |
| Intangible Assets | $7.02B | 16.1% |
| Other Assets | $9.43B | 21.6% |
Liabilities Breakdown
Total Liabilities: $19.44B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.14B | 5.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $18.30B | 94.1% |